These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 20584124)

  • 1. Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study.
    Carson C; Wyllie M
    J Sex Med; 2010 Sep; 7(9):3179-89. PubMed ID: 20584124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
    Dinsmore WW; Wyllie MG
    BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation.
    Dinsmore WW; Hackett G; Goldmeier D; Waldinger M; Dean J; Wright P; Callander M; Wylie K; Novak C; Keywood C; Heath P; Wyllie M
    BJU Int; 2007 Feb; 99(2):369-75. PubMed ID: 17129234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical lidocaine-prilocaine spray for the treatment of premature ejaculation: a proof of concept study.
    Henry R; Morales A
    Int J Impot Res; 2003 Aug; 15(4):277-81. PubMed ID: 12934056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX).
    McMahon C; Althof S; Rosen R; Giuliano F; Miner M; Osterloh IH; Muirhead GJ; Harty B;
    J Sex Med; 2019 Aug; 16(8):1178-1187. PubMed ID: 31351659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of epelsiban in the treatment of men with premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose study.
    Shinghal R; Barnes A; Mahar KM; Stier B; Giancaterino L; Condreay LD; Black L; McCallum SW
    J Sex Med; 2013 Oct; 10(10):2506-17. PubMed ID: 23937679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study.
    Busato W; Galindo CC
    BJU Int; 2004 May; 93(7):1018-21. PubMed ID: 15142155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX).
    Althof S; Osterloh IH; Muirhead GJ; George K; Girard N;
    J Sex Med; 2019 Aug; 16(8):1188-1198. PubMed ID: 31351660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of local anaesthetics in premature ejaculation.
    Wyllie MG; Powell JA
    BJU Int; 2012 Dec; 110(11 Pt C):E943-8. PubMed ID: 22758648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation.
    Aversa A; Pili M; Francomano D; Bruzziches R; Spera E; La Pera G; Spera G
    Int J Impot Res; 2009; 21(4):221-7. PubMed ID: 19474796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
    Shabsigh R; Patrick DL; Rowland DL; Bull SA; Tesfaye F; Rothman M
    BJU Int; 2008 Sep; 102(7):824-8. PubMed ID: 18647300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tramadol HCL has promise in on-demand use to treat premature ejaculation.
    Salem EA; Wilson SK; Bissada NK; Delk JR; Hellstrom WJ; Cleves MA
    J Sex Med; 2008 Jan; 5(1):188-93. PubMed ID: 17362279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature ejaculation: bother and intravaginal ejaculatory latency time in Iran.
    Zargooshi J
    J Sex Med; 2009 Dec; 6(12):3478-89. PubMed ID: 19732308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes.
    Bar-Or D; Salottolo KM; Orlando A; Winkler JV;
    Eur Urol; 2012 Apr; 61(4):736-43. PubMed ID: 21889833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature ejaculation: results from a five-country European observational study.
    Giuliano F; Patrick DL; Porst H; La Pera G; Kokoszka A; Merchant S; Rothman M; Gagnon DD; Polverejan E;
    Eur Urol; 2008 May; 53(5):1048-57. PubMed ID: 17950985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for erectile dysfunction in men with lifelong premature ejaculation--Is the Sexual Health Inventory for Men (SHIM) reliable?
    McMahon CG
    J Sex Med; 2009 Feb; 6(2):567-73. PubMed ID: 19215618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical study of SS-cream in patients with lifelong premature ejaculation.
    Choi HK; Jung GW; Moon KH; Xin ZC; Choi YD; Lee WH; Rha KH; Choi YJ; Kim DK
    Urology; 2000 Feb; 55(2):257-61. PubMed ID: 10688090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The link between penile hypersensitivity and premature ejaculation.
    Wyllie MG; Hellstrom WJ
    BJU Int; 2011 Feb; 107(3):452-7. PubMed ID: 20553259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving therapeutic strategies for premature ejaculation: The search for on-demand treatment - topical versus systemic.
    Morales A
    Can Urol Assoc J; 2012 Oct; 6(5):380-5. PubMed ID: 23093633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials.
    Porst H; McMahon CG; Althof SE; Sharlip I; Bull S; Aquilina JW; Tesfaye F; Rivas DA
    J Sex Med; 2010 Jun; 7(6):2231-2242. PubMed ID: 20412423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.